Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sigma Healthcare Ltd ( (AU:SIG) ) has issued an update.
Sigma Healthcare has notified the market of the issue of 2,403,962 unquoted performance rights under its employee incentive scheme, effective 9 January 2026. The new grants, which are not intended to be quoted on the ASX, form part of Sigma’s broader approach to staff remuneration and retention, aligning employee rewards with company performance and potentially impacting future equity dilution for existing shareholders.
The most recent analyst rating on (AU:SIG) stock is a Buy with a A$3.39 price target. To see the full list of analyst forecasts on Sigma Healthcare Ltd stock, see the AU:SIG Stock Forecast page.
More about Sigma Healthcare Ltd
Sigma Healthcare Limited is an Australian-listed company operating in the healthcare and pharmaceutical distribution sector, with its securities traded on the ASX under the code SIG. The company is involved in supplying pharmaceutical products and related services, supporting pharmacies and healthcare providers across its market.
Average Trading Volume: 15,600,081
Technical Sentiment Signal: Buy
Current Market Cap: A$33.53B
See more insights into SIG stock on TipRanks’ Stock Analysis page.